Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Friday, May 17, 2024.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Bull Market Weakness (+75) - XERS is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on XERS as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid XERS?
MarketClub looks at technical strength and momentum to determine if the timing is right for XERS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for XERS
The long-term trend has been DOWN since Apr 8th, 2024 at 2.00
The intermediate-term trend has been UP since May 6th, 2024 at 1.96
The short-term trend has been UP since May 13th, 2024 at 1.91
Smart Scan Analysis for XERS
Based on our trend formula, XERS is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.980 | 2.070 | 1.930 | 2.025 | +0.045 |
| Prev. Close | Volume | Bid | Ask | Time |
| 2.020 | 1314034 | 2024-05-16 15:59:53 |
| Year High | 27.9826 | Year High Date | 2018-09-12 |
| Year Low | 15.75 | Year Low Date | 2018-06-21 |
| 52wk High | 3.26 | 52wk High Date | 2024-02-15 |
| 52wk Low | 1.46 | 52wk Low Date | 2023-11-15 |
| Average Volume | 1,308,071 | Shares Outstanding | 148,256 |
| Market Cap | 275M | Assets | 336,616,000M |
| Liabilities | 345,794,000M | P/E Ratio | -4.52630000 |
| Volatility | 56.41 |